drug
-
Health & Wellness
A Glimmer of Hope Tempered by Persistent Barriers: New Hunter Syndrome Drug Offers Promise, But Age Restrictions Ignite Fierce Debate
The recent accelerated approval of Avlayah (tividenofusp alfa-eknm) by the U.S. Food and Drug Administration (FDA) for Hunter syndrome represents…
Read More » -
Health & Wellness
Ben Sasse on enrolling in Rev Med’s drug trial, more ADC investment, and other biotech news from The Readout
The recent unveiling of highly promising results from Revolution Medicines’ pancreatic cancer pill trial has ignited significant interest, not only…
Read More » -
Health & Wellness
FDA Mandates Clinical Trial Data Reporting Amidst Transparency Push; Novo Nordisk and OpenAI Forge AI Drug Discovery Alliance
The U.S. Food and Drug Administration (FDA) has initiated a significant push for greater transparency in clinical research by dispatching…
Read More »